GHISLAINE MAXWELL ACCT. For the Period 11/I/II to 11/3WI I Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Onginal Cost Gain/Loss Accrued Div. Yield US Large Cap Equity WELLS FARGO & CO 949746-10-1 WFC 25.86 478 000 12.387 OB N A" N/A 229.44 1.86% Total US Large Cap Equity US Small/Mid Cap Equity GERON COFtP 374163-10-3 GERN $283.435.07 $102823.00 ($44.721.00) $6.786.48 2.04% $694.34 1.67 3,000.000 5 WO 00 18,129.32 (13,119.32) Non-US Equity P ACCENTURE PLC-CL A 57.93 N/A " 1 N/A 2.33% G1151C-10-1 ACN P ACE LTD NEW 69.53 N/A " N/A 2.01% H0023R-10-5 ACE AKZO NOBEL N V 50.51 149.000 7,525.82 N/A " N/A MIN NL0000009132/SEDOL 5458314 NO1803-90-2 EUR ALLIANZ SE HOLDING 102.59 77.000 7,899.44 N/A " 1 N/A ISIN DE00084O4005 SEDOL 5231485 D03080-90-6 EUR ATLAS COPCO AB-A SHS 21.43 442.000 9,470.63 N/A " N/A ISIN SE0000101032 SEDOL B1OGR41 W10020-92-8 SEK JP Morgan Page 8 of 66 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048203 SDNY_GM_00317401 EFTA01520859